PT - JOURNAL ARTICLE AU - Turner, Joshua R. AU - Cheng, Justin AU - Chow, Judy AU - Hassanali, Farhanna AU - Sevigny, Hayley AU - Sperduti, Michael AU - Chan Carusone, Soo AU - Dagenais, Matthieu AU - O’Brien, Kelly K. TI - Wireless physical activity monitor use among adults living with HIV in a community-based exercise intervention study: a quantitative longitudinal observational study AID - 10.1101/2022.09.25.22280346 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.25.22280346 4099 - http://medrxiv.org/content/early/2022/09/27/2022.09.25.22280346.short 4100 - http://medrxiv.org/content/early/2022/09/27/2022.09.25.22280346.full AB - Objectives Our aim was to examine Wireless Physical Activity Monitor (WPAM) use and its associations with contextual factors (age, highest education level, social support, mental health) among adults living with HIV engaged in a community-based exercise (CBE) intervention.Design Quantitative longitudinal observational study.Setting Toronto YMCA, Ontario, Canada.Participants Eighty adults living with HIV who initiated the CBE intervention.Interventions Participants received a WPAM to track physical activity during a 25-week CBE intervention involving thrice-weekly exercise, supervised weekly (Phase 1) and a 32-week follow-up involving independent thrice-weekly exercise (Phase 2).Outcome measures Uptake was measured as participants who consented to WPAM use at intervention initiation. Usage was defined as the median proportion of days participants had great than 0 steps out of the total number of days in the study. We measured contextual factors using a baseline demographic questionnaire (age, highest education level), and median scores from the Medical Outcomes Study-Social Support Scale and Patient Health Questionnaire (mental health), where higher scores indicated greater social support and mental health concerns, respectively. We calculated Spearman correlations between WPAM usage and contextual factors defined as weak (ρ≥0.2, moderate (ρ≥0.4), strong (ρ≥0.6), or very strong (ρ≥0.8).Results Seventy-six of 80 participants (95%) consented to WPAM use. In Phase 1, 66% of participants (n=76) used the WPAM at least one day. Median WPAM usage was 50% (25th, 75th percentile: 0%, 87%; n=76) of days enrolled in Phase 1 and 23% (0%, 76%; n=64) of days during Phase 2. Correlation coefficients ranged from weak for age (ρ=0.26) and mental health scores (ρ=-0.25) to no correlation (highest education level, social support).Conclusions Most adults living with HIV consented to WPAM use, however, usage declined over time. Future implementation of WPAMs should consider factors to promote sustained usage by adults living with HIV.Trial Registration NCT02794415STRENGTHS & LIMITATIONS OF THIS STUDYTo our knowledge, this is the first quantitative study to measure wireless physical activity monitor (WPAM) use among adults living with HIV engaged in a community-based exercise intervention.The longitudinal study design enabled us to examine changes in WPAM use over time.Utilizing objective measures of physical activity (WPAM) and self-reported (questionnaire) measures of physical activity enabled us to investigate associations of different measurement approaches of physical activity levels among adults living with HIV.Limitations included variable and incomplete participant data across multiple data sources such as, WPAM synchronization, self-reported step count, and completion of weekly exercise questionnaires.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02794415Funding StatementThis study was funded by the Canadian Institutes of Health Research (CIHR) HIV/AIDS Community-Based Research (CBR) Program and the Canada Research Chairs Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Health Sciences Research Ethics Board of the University of Toronto gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.